Analysis updated Sep 24, 2026 — scores and signals refreshed daily.
ELEVANCE HEALTH INC (ELV) stock analysis — updated Sep 24, 2026: Q-Score 63/100 — Buy. AI alpha score, Graham intrinsic value, ML forecast, technicals and insider activity.
Current Q-Score verdict: Buy (63.0) (grade B). 33 signals analyzed (28 differentiated alt-data).
StoQuant's analysis of ELEVANCE HEALTH INC (ELV) is refreshed every trading day. The Q-Score combines discounted cash flow valuation, earnings quality, competitive moat, analyst consensus, ML return forecasts, technical momentum and market sentiment into a single 0–100 composite. Insider transactions from SEC Form 4 filings, the Graham intrinsic value estimate and signal coverage are recomputed as new data arrives, so this page always reflects the latest available information.
ELV stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-05-14 | $398.67 | $391.51 | $396.80 |
| 2026-05-27 | $392.67 | $386.76 | $391.47 |
| 2026-06-08 | $421.00 | $410.50 | $418.15 |
| 2026-06-18 | $393.91 | $387.08 | $388.50 |
| 2026-07-01 | $416.26 | $388.70 | $416.19 |
| 2026-07-14 | $436.24 | $422.32 | $426.79 |
| 2026-07-24 | $382.79 | $375.91 | $377.68 |
| 2026-08-05 | $392.43 | $370.47 | $391.24 |
| 2026-08-17 | $400.17 | $388.17 | $390.24 |
| 2026-08-27 | $404.09 | $395.22 | $399.11 |
| 2026-09-09 | $409.43 | $391.40 | $396.90 |
| 2026-09-21 | $411.48 | $406.20 | $409.31 |
How ELEVANCE HEALTH INC stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| AZN | AstraZeneca PLC | $290.7B | — |
| NVS | Novartis AG | $287.1B | — |
| NVO | Novo Nordisk A/S | $200.3B | — |
| SNY | Sanofi | $107.6B | — |
| GSK | GSK plc | $102.1B | — |
View all Health Care stocks by valuation and signals →
ELEVANCE HEALTH INC (ELV) scores Buy (63.0), with no measured dimension below 54. Its highest are technicals at 89, earnings quality at 85, competitive moat at 74, across 5 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| technicals | 89 |
| earnings quality | 85 |
| competitive moat | 74 |
| analyst consensus | 70 |
| ML forecast | 54 |
StoQuant analyzes 33 signals (28 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
ELEVANCE HEALTH INC (ELV) ML Forecast — StoQuant's ML model generates a probability estimate for ELV's outperformance vs. the S&P 500, with named drivers (e.g., "earnings surprise upcoming", "insider cluster buy", "RSI reversal") and confidence intervals. Updated daily pre-market.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on ELEVANCE HEALTH INC (ELV): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/ELV"><img src="https://stoquant.com/badge/ELV.svg" alt="ELEVANCE HEALTH INC (ELV) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.